Orphan Drugs in Canada: A “One Size Fits All” Regulatory Regime By Eileen McMahon and Denise Ramsden Introduction Medicines targeting rare diseases, also known as orphan drugs,[1] once faced an uphill battle for research funding and market approval. The need for robust commercial incentives to create rare disease treatments spurred the establishment [...]
May 18–20, 2021 | Virtual Event
The Summer Learning Series brings the top thinkers and leaders of our industry to speak on a broad array of topics essential to the food and drug law professional, covering matters that perhaps we all wish we knew a bit more about as we work and converse with clients, colleagues, and the FDA. Join [...]
Update Magazine | Summer 2021
Recorded April 27, 2021 | On-Demand Webinar
April 22, 2021 | 5:00 PM EDT | Virtual Event
April 20–22, 2021 | Virtual Course
April 15, 2021 | 12:00–1:00 PM EDT | Virtual Event
Recorded April 8, 2021 | On-Demand Webinar
March 18, 2021 | 12:00–1:00 PM EDT | Virtual Event
